| Literature DB >> 25244285 |
Eirini Kouloura1, Eirini Danika2, Sothea Kim3, Mélanie Hoerlé4, Muriel Cuendet5, Maria Halabalaki6, Leandros A Skaltsounis7.
Abstract
Micromelum falcatum, a medicinal plant of the Rutaceae family, has been used in the Traditional Chinese Medicine (TCM) mainly against colds and rheumatoid arthritis. Despite its traditional use the association of its constituents with possible anti-inflammatory activity has not been explored. During this study, a rapid UPLC-ESI(+)-HRMS method was developed for the profiling of M. falcatum leave extracts and the targeted isolation of coumarin constituents. Based on chromatographic, spectroscopic and spectrometric features several 7-oxygenated coumarin derivatives were detected. After targeted isolation, eight coumarins, among them three new natural products, namely microfalcrin, microcoumaririn and micromelosidester, were purified using semi-preparative HPLC and unambiguously identified by 1 and 2D NMR. Furthermore, important spectrometric characteristics were revealed based on the HRMS and HRMS/MS spectra of the isolated 7-oxygenated coumarins facilitating their identification in complex mixtures. Finally, the anti-inflammatory properties of the extracts and representative compounds were evaluated by measuring the inhibition of the pro-inflammatory mediator NF-κB induction and nitric oxide (NO) production.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25244285 PMCID: PMC6271814 DOI: 10.3390/molecules190915042
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Base peak chromatograms of each extract obtained from M. falcatum in positive ionization mode.
7-Oxygenated coumarin derivatives detected in M. falcatum extracts based on literature and UPLC-ESI(+)-HRMS/MS data.
| No | Rt (min) | [M+Na]+ | Molecular Formula | RDB | Delta (ppm) | MS/MS (% Intensity) | Suggested Compounds (Annotation) | Extract |
|---|---|---|---|---|---|---|---|---|
| 1 | 4.10 | 315.0842 | C15H16O6Na | 7.5 | 1.018 | 297.0737 (24) | Unknown (Coumarin with aliphatic chain) | EtOAc, DCM, EtOAc_A |
| 285.0737 (5) | ||||||||
| 227.0317 (100) | ||||||||
| 2 | 4.37 | 315.0842 | C15H16O6Na | 7.5 | 0.922 | 297.0737 (17) | Unknown | EtOAc, DCM, EtOAc_A, EtOAc_B |
| 285.0737 (3) | ||||||||
| 227.0316 (100) | ||||||||
| 3 | 5.20 | 357.0947 | C17H18O7Na | 8.5 | 0.633 | 297.0736 (100) | Micromeloside D | DCM, EtOAc_A |
| 4 | 5.68 | 297.0737 | C15H14O5Na | 8.5 | 1.196 | Micromeloside A/Hopeyhopin | EtOAc, DCM, EtOAc_A, EtOAc_B | |
| 5 | 5.88 | 357.0948 | C17H18O7Na | 8.5 | 1.053 | 297.0737 (56) | Micromeloside D | DCM, EtOAc_A |
| 227.0317 (100) | ||||||||
| 6 | 6.06 | 299.0893 | C15H16O5Na | 7.5 | 0.887 | 281.0788 (100) | Hydramicromelin A/Murrangatin | EtOAc |
| 269.0788 (81) | ||||||||
| 7 | 6.12 | 311.0529 | C15H12O6Na | 9.5 | 1.095 | Micromelin | DCM, EtOAc_A | |
| 8 | 6.29 | 301.1050 | C15H18O5Na | 7.5 | 1.312 | 283.0945 (100) | Unknown | DCM, EtOAc_A |
| 9 | 6.30 | 315.0843 | C15H16O6Na | 7.5 | 1.113 | 297.0852 (100) | Unknown | EtOAc, EtOAc_B |
| 10 | 6.42 | 295.0579 | C15H12O5Na | 9.5 | 0.662 | Microminutin(Microminutin, | EtOAc, DCM, EtOAc_A, EtOAc_B, MeOH_A, MeOH_B | |
| 11 | 6.55 | 311.0527 | C15H12O6Na | 9.5 | 1.053 | Micromelin | EtOAc, DCM, EtOAc_B | |
| 12 | 7.54 | 399.1416 | C20H24O7Na | 8.5 | 0.365 | 297.0736 (100) | Micromarin B/C | EtOAc, DCM, EtOAc_A, EtOAc_B, MeOH_A, MeOH_B |
| 13 | 7.73 | 399.1416 | C20H24O7Na | 8.5 | 0.516 | 297.0736 (100) | Micromarin B/C | EtOAc, EtOAc_B |
| 14 | 8.17 | 399.1416 | C20H24O7Na | 8.5 | 0.516 | 381.1312 (5) | Micromarin B/C | EtOAc, DCM, EtOAc_A, EtOAc_B, MeOH_A, MeOH_B |
| 297.0737 (75) | ||||||||
| 227.0317 (100) | ||||||||
| 15 | 8.44 | 343.1156 | C17H20O6Na | 7.5 | 1.138 | 315.0843 (100) | Micromeloside B | DCM, EtOAc_A, EtOAc_B |
| 297.0737 (60) | ||||||||
| 16 | 8.81 | 413.1573 | C21H26O7Na | 8.5 | 0.522 | 311.0894 (100) | Micromeloside C | EtOAc_A, MeOH_A |
| 17 | 9.52 | 409.1624 | C22H26O6Na | 9.5 | 0.465 | 289.1050 (100) | Unknown | EtOAc, DCM, EtOAc_A, EtOAc_B, MeOH_A, MeOH_B |
| 18 | 10.27 | 381.1311 | C20H22O6Na | 9.5 | 0.710 | 279.0630 (100) | Micromarin A | EtOAc, DCM, EtOAc_B, MeOH_A |
| 19 | 10.55 | 381.1312 | C20H22O6Na | 9.5 | 0.893 | 353.1363 (28) | Micromarin A | EtOAc, EtOAc_B, MeOH_A |
| 279.0630 (100) | ||||||||
| 257.0812 (41) |
Figure 2Structures of compounds 1–8.
NMR Spectroscopic Data (600 MHz, CD3OH) for compounds 1–3.
| Position | 1 | 2 | 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| δH ( | δC | HMBC | δH ( | δC | HMBC | δH ( | δC | HMBC | |
| 2 | 163.1 | 163.0 | 162.6 | ||||||
| 3 | 6.25, d (9.4) | 113.6 | 2, 9 | 6.29, d (9.4) | 114.0 | 2, 9 | 6.26,d (9.4) | 113.8 | 2, 9 |
| 4 | 7.87, d (9.4) | 146.5 | 2, 3, 5, 10 | 7.95, d (9.4) | 146.4 | 2, 5, 9, 10 | 7.90,d (9.4) | 146.5 | 2, 5, 9, 10 |
| 5 | 7.55, d (8.8) | 130.7 | 4, 7, 10 | 7.73, d (8.8) | 132.2 | 4, 7, 10 | 7.63,d (8.8) | 131.4 | 4, 7, 9, 10 |
| 6 | 7.05, d (8.8) | 109.9 | 8, 9 | 7.17, d (8.8) | 109.8 | 7, 8, 9 | 7.09,d (8.8) | 109.9 | 7, 9, 10 |
| 7 | 162.4 | 162.3 | 162.9 | ||||||
| 8 | 117.9 | 107.5 | 109.2 | ||||||
| 9 | 114.8 | 115.0 | 114.8 | ||||||
| 10 | 154.5 | 154.4 | 154.9 | ||||||
| 1' | 5.37, d (8.8) | 70.6 | 7, 8, 10, 2' | 5.52, d (5.9) | 78.3 | 6, 7, 10, 2' | |||
| 2' | 4.94, d (8.8) | 77.2 | 1', 3', 4', 5' | 172.6 | 6.11, d (5.9/1.8) | 78.2 | 3', 5' | ||
| 3' | 150.4 | 123.4 | 148.3 | ||||||
| 4'a | 4.08, dt (15.3/1.8) | 62.8 | 3', 5' | 165.1 | 4.74, dt (13.0/2.0) | 72.5 | 8, 1', 3' | ||
| 5'a | 4.92, d (1.8) | 112.0 | 2', 4' | 6.18, brs | 101.4 | 5.28, m | 109.6 | 2', 3', 4' | |
| 1'' | 174.6 | ||||||||
| 2'' | 2.21, m | 44.5 | 1'', 3'', 4'', 5'' | ||||||
| 3'' | 2.01, m | 27.3 | 1'', 4'', 5'' | ||||||
| 4'' | 0.88, d (6.7) | 22.7 | 2'', 3'', 5'' | ||||||
| 5'' | 0.89, d (6.7) | 22.7 | 2'', 3'', 4'' | ||||||
| CH3O | 3.96, s | 57.0 | 7 | 3.93, s | 57.2 | 7 | 3.93, s | 57.1 | 7 |
| CH3 | 1.96, s | 13.3 | 8, 2', 3', 4', 5' | ||||||
Figure 3Characteristic HRMS and HRMS/MS spectra of representative 7-methoxylated coumarins.